Akoya Biosciences Files 8-K Report
| Field | Detail |
|---|---|
| Company | Akoya Biosciences, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: AKYA
TL;DR
AKYA filed an 8-K on 6/2/25, check for "Other Events" details.
AI Summary
On June 2, 2025, Akoya Biosciences, Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events" as of the reporting date. No specific transactions or material events are detailed in the provided excerpt.
Why It Matters
This filing signals that Akoya Biosciences is making a regulatory disclosure to the SEC. Investors should review the full filing for details on any significant events.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification without specific financial or operational details that would indicate immediate risk.
Key Players & Entities
- Akoya Biosciences, Inc. (company) — Registrant
- 0001711933 (company) — Central Index Key
- 001-40344 (company) — SEC File Number
- 475586242 (company) — IRS Employer Identification No.
- June 2, 2025 (date) — Date of Report
FAQ
What is the purpose of this 8-K filing by Akoya Biosciences, Inc.?
The 8-K filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating that Akoya Biosciences, Inc. is reporting on "Other Events" as of June 2, 2025.
When was this 8-K filing submitted?
The filing was made on June 2, 2025.
What is Akoya Biosciences, Inc.'s principal executive office address?
The principal executive offices are located at 100 Campus Drive, 6th Floor, Marlborough, MA 01752.
What is Akoya Biosciences, Inc.'s telephone number?
The registrant's telephone number is (855) 896-8401.
What is Akoya Biosciences, Inc.'s state of incorporation?
Akoya Biosciences, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Akoya Biosciences, Inc..